BIO-OPTIMIZERSRESEARCH INSTITUTE • 0.00% THC
Open-Access Neuropharmacology • Sub-45nm Pharmacokinetics • Wearable Biometrics

Democratizing Cannabinoid & Systems-Biology Science.

Most cannabinoid supplements ignore first-pass hepatic metabolism—losing ~90% of their active compounds to CYP450 liver degradation. We translate peer-reviewed receptor pharmacology and human pharmacokinetic trials into open-access calculators and 100% non-psychoactive (0.00% THC) clinical protocols.

📬 Community Knowledge Network

Get the Weekly Cannabinoid & Circadian Research Digest

Join bio-optimizers, clinicians, and wearable power-users receiving our weekly plain-English synthesis of peer-reviewed cannabinoid trials, bioavailability studies, and HRV recovery protocols.

Core Curriculum • Foundations of Minor Cannabinoid Science

The 4 Pillars of Precision Cannabinoid Pharmacology

Before buying any supplement, understand the pharmacokinetic bottlenecks and receptor affinities proven in human clinical trials:

01 // PHARMACOKINETICS & PARACELLULAR TRANSPORT

Sub-45nm Nano-Emulsions vs. First-Pass Hepatic Loss

Standard MCT oil tinctures require bile-salt emulsification and enter the portal vein, where hepatic CYP2C9 and CYP3A4 enzymes degrade ~90% of the dose (6–10% bioavailability). Acoustic shearing below 45 nanometers enables direct lymphatic absorption—achieving 36% bioavailability (4.2x AUC) and a 20-minute Tmax.

02 // SLEEP ARCHITECTURE • NCT05511818 (N > 1,000)

Nano-CBN & Apigenin vs. Exogenous Melatonin

Randomized double-blind trials confirm 25–50 mg CBN significantly reduces nocturnal awakenings (p=0.023) without hormone-receptor desensitization. Paired with Apigenin (GABA-A positive allosteric modulator & CD38 inhibitor) and Mag L-Threonate, it elevates parasympathetic nocturnal HRV.

03 // CORTICAL FOCUS • PREFRONTAL α2-ADRENERGIC AGONISM

Cannabigerol (CBG) & Catecholamine Efficiency

Unlike caffeine, which triggers systemic sympathetic vasoconstriction, CBG acts as a nanomolar α2-adrenergic receptor agonist in the medial prefrontal cortex—enhancing pyramidal neuron firing efficiency and verbal working memory when paired with Citicoline and Lion's Mane.

04 // METABOLIC ENDOCRINOLOGY • DIABETES CARE TRIAL

THCV Neutral CB1 Antagonism & AMPK Activation

Human double-blind trials (Jadoon et al.) show Δ9-THCV acts as a neutral CB1 antagonist, blunting hypothalamic hunger signaling and lowering fasting plasma glucose. Combined with 5x-bioavailable Dihydroberberine and Tributyrin, it optimizes metabolic flexibility during fasting.

Open-Access Knowledge Library

Peer-Reviewed Monographs & Interactive Calculators

🔬 CLINICAL_COMPARISONPeer-Reviewed Monograph

Nano Emulsified CBN vs Melatonin: Decoding Sleep Latency and Receptor Pharmacology

Explore the peer-reviewed science of nano emulsified CBN vs melatonin. Understand CB1/CB2 receptor pharmacology, sub-45nm lymphatic micellar absorption, and how the Circadian Deep Nano-CBN + Magnesium Stack reduces sleep latency.

Read Full Monograph & Bioavailability Model→
🔬 CLINICAL_COMPARISONPeer-Reviewed Monograph

CBG vs L-Theanine: Pharmacological Mechanics for Caffeine Jitters and Sustained Cognitive Focus

Explore the receptor pharmacology of CBG vs L-Theanine for caffeine jitters, anxiety, and cognitive focus. Discover how advanced micellar delivery optimizes bioavailability.

Read Full Monograph & Bioavailability Model→
🔬 CLINICAL_COMPARISONPeer-Reviewed Monograph

THCV vs. Berberine for Intermittent Fasting Glucose Control

Explore the peer-reviewed clinical pharmacology comparing THCV and dihydroberberine for intermittent fasting, metabolic flexibility, and optimal blood glucose control.

Read Full Monograph & Bioavailability Model→
🔬 PHARMACOKINETICSPeer-Reviewed Monograph

Overcoming Hepatic First-Pass Metabolism: Nano Liposomal CBN vs Standard Oil Tinctures

Explore the peer-reviewed science of nano liposomal CBN delivery. Compare sub-45nm lymphatic absorption against standard oil tinctures, first-pass hepatic loss, and receptor pharmacology.

Read Full Monograph & Bioavailability Model→
🔬 CLINICAL_COMPARISONPeer-Reviewed Monograph

Apigenin vs. CBN for Deep REM Sleep Architecture

Discover the rigorous science behind Apigenin vs. CBN for deep REM sleep architecture. Explore GABA-A modulation, cannabinoid receptor pathways, and lymphatic micellar delivery.

Read Full Monograph & Bioavailability Model→
🔬 CLINICAL_COMPARISONPeer-Reviewed Monograph

Systems-Biology Analysis: Magnesium L-Threonate vs. Magnesium Bisglycinate with Advanced Micellar CBN for Sleep Architecture

Explore the peer-reviewed receptor pharmacology of magnesium threonate, bisglycinate, and advanced lymphatic micellar CBN for deep sleep optimization.

Read Full Monograph & Bioavailability Model→
From Literature to Formulation

Applied Clinical Formulations (0.00% Total THC)

Formulated strictly to match the clinical dosages and sub-45nm delivery specifications established in our research library. Legal to ship to all 50 states.

☀️ AM COGNITIVE & EXECUTIVE FLOW

Neuro-Flow (AM)

30mg Micro-Encapsulated CBG + 10mg THCV + 250mg Citicoline + 350mg NALT + 500mg Lion's Mane

  • ✓ α2-Adrenergic prefrontal focus without caffeine jitters
  • ✓ Supports acetylcholine & Nerve Growth Factor (NGF)
$75 Auto-Ship / Included in $118 24-Hr System →
🌙 PM SLEEP ARCHITECTURE & HRV

Circadian Deep (PM)

25mg Sub-45nm Nano-CBN + 50mg Nano-CBD + 50mg Apigenin + 200mg Mag L-Threonate + 200mg L-Theanine

  • ✓ Slow-wave & REM sleep consolidation without melatonin fog
  • ✓ Parasympathetic GABA-A synergy for +14% Oura/Whoop HRV
🧪 Reserve Batch #001 Allocation ($118) →
🔥 GLYCEMIC & AMPK OPTIMIZATION

Metabolic Fast

15mg THCV + 15mg CBDv + 300mg Micronized PEA + 150mg Dihydroberberine + 300mg Tributyrin

  • ✓ Neutral CB1 receptor antagonism suppresses fasting hunger
  • ✓ 5x bioavailable Dihydroberberine AMPK glucose disposal
$79 Auto-Ship / Complete 3-SKU System ($160) →